Form D Explorer

Source evidence

CAD Therapeutics, Inc. · 0002157566-26-000001

D filed Oct. 2, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
NEW YORK
street1
6 ST JOHNS LN
zipCode
10013
entityName
CAD Therapeutics, Inc.
entityType
Corporation
stateOrCountry
NY
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold4000000number4000000/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount10000000number10000000/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count2number2/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 7e144effdd2bbfb932a1feeee57e99a47fecfca3f24fc5d37758b1227541b256. This proves extraction identity, not the accuracy of the filer's claims.